​

Encompass Health (EHC) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

EHC Stock Forecast

Encompass Health (EHC) stock forecast, based on 25 Wall Street analysts, predicts a 12-month average price target of $97.00, with a high of $110.00 and a low of $83.00. This represents a -6.14% decline from the last price of $103.35.

$65 $74 $83 $92 $101 $110 High: $110 Avg: $97 Low: $83 Last Closed Price: $103.35

EHC Stock Rating

Encompass Health stock's rating consensus is Buy, based on 25 Wall Street analysts. The breakdown includes 1 Strong Buy (4.00%), 20 Buy (80.00%), 3 Hold (12.00%), 1 Sell (4.00%), and 0 Strong Sell (0.00%).

Buy
Total 25 1 3 20 1 Strong Sell Sell Hold Buy Strong Buy

EHC Price Target Upside V Benchmarks

TypeNameUpside
StockEncompass Health-6.14%
SectorHealthcare Stocks 35.25%
IndustryMedical Care Facilities Stocks23.83%

Price Target Trends

1M3M12M
# Anlaysts--4
Avg Price Target--$101.25
Last Closing Price$103.35$103.35$103.35
Upside/Downside---2.03%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 25211---13
Mar, 25211---13
Feb, 25211---13
Jan, 25211---13
Dec, 24211---13
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 26, 2024Ben HendrixRBC Capital$105.00$96.758.53%1.60%
Sep 25, 2024AJ RiceUBS$110.00$95.2615.47%6.43%
May 22, 2024Frank MorganRBC Capital$95.00$85.8610.65%-8.08%
Apr 25, 2024Ann HynesMizuho Securities$95.00$82.8014.73%-8.08%
Mar 28, 2024Andrew MokBarclays$101.00$81.7923.49%-2.27%
May 03, 2022RBC Capital$85.00$68.2424.56%-17.76%
May 02, 2022Raymond James$85.00$68.8323.49%-17.76%
Apr 29, 2022Credit Suisse$83.00$68.4621.24%-19.69%
Apr 29, 2021Scott FidelStephens$100.00$84.6218.18%-3.24%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 29, 2024UBSBuyBuyhold
Oct 29, 2024KeyBancOverweightOverweighthold
Oct 29, 2024BarclaysOverweightOverweighthold
Oct 11, 2024Truist FinancialUnderperformUnderperformhold
Oct 10, 2024KeyBancOverweightinitialise
Sep 26, 2024RBC CapitalOutperformOutperformhold
Sep 25, 2024UBSBuyBuyhold
Aug 06, 2024RBC CapitalUnderperformUnderperformhold
Jul 10, 2024StephensStrong BuyStrong Buyhold
Jul 10, 2024BarclaysOverweightOverweighthold

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$2.87$4.15$2.72$3.54$4.56----
Avg Forecast$2.82$4.30$2.80$3.51$4.30$4.77$5.30$5.57$5.57
High Forecast$2.85$4.35$2.82$3.55$4.37$5.15$5.52$5.86$5.63
Low Forecast$2.79$4.25$2.77$3.48$4.25$4.49$5.00$5.28$5.49
Surprise %1.77%-3.49%-2.86%0.85%6.05%----

Revenue Forecast

$4B $5B $5B $6B $7B $8B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$4.64B$5.12B$4.35B$4.80B$5.37B----
Avg Forecast$4.64B$5.11B$4.33B$4.79B$5.35B$5.83B$6.32B$6.79B$7.19B
High Forecast$4.68B$5.15B$4.36B$4.80B$5.36B$5.88B$6.33B$6.83B$7.26B
Low Forecast$4.59B$5.06B$4.30B$4.74B$5.33B$5.77B$6.32B$6.75B$7.11B
Surprise %0.19%0.25%0.34%0.20%0.44%----

Net Income Forecast

$200M $280M $360M $440M $520M $600M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$284.20M$412.20M$271.00M$352.00M$455.70M----
Avg Forecast$277.82M$373.96M$357.01M$361.60M$431.50M$485.48M$533.95M$564.24M$564.24M
High Forecast$333.39M$448.76M$428.41M$433.92M$442.51M$522.11M$559.15M$594.04M$570.57M
Low Forecast$222.26M$299.17M$285.61M$289.28M$430.33M$455.07M$506.79M$534.44M$555.99M
Surprise %2.29%10.22%-24.09%-2.65%5.61%----

EHC Forecast FAQ

Is Encompass Health stock a buy?

Encompass Health stock has a consensus rating of Buy, based on 25 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 20 Buy, 3 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Encompass Health is a favorable investment for most analysts.

What is Encompass Health's price target?

Encompass Health's price target, set by 25 Wall Street analysts, averages $97 over the next 12 months. The price target range spans from $83 at the low end to $110 at the high end, suggesting a potential -6.14% change from the previous closing price of $103.35.

How does Encompass Health stock forecast compare to its benchmarks?

Encompass Health's stock forecast shows a -6.14% downside, underperforming the average forecast for the healthcare stocks sector (35.25%) and underperforming the medical care facilities stocks industry (23.83%).

What is the breakdown of analyst ratings for Encompass Health over the past three months?

  • April 2025: 15.38% Strong Buy, 84.62% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 15.38% Strong Buy, 84.62% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 15.38% Strong Buy, 84.62% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Encompass Health’s EPS forecast?

Encompass Health's average annual EPS forecast for its fiscal year ending in December 2025 is $4.77, marking a 4.61% increase from the reported $4.56 in 2024. Estimates for the following years are $5.3 in 2026, $5.57 in 2027, and $5.57 in 2028.

What is Encompass Health’s revenue forecast?

Encompass Health's average annual revenue forecast for its fiscal year ending in December 2025 is $5.83B, reflecting a 8.44% increase from the reported $5.37B in 2024. The forecast for 2026 is $6.32B, followed by $6.79B for 2027, and $7.19B for 2028.

What is Encompass Health’s net income forecast?

Encompass Health's net income forecast for the fiscal year ending in December 2025 stands at $485.48M, representing an 6.54% increase from the reported $455.7M in 2024. Projections indicate $533.95M in 2026, $564.24M in 2027, and $564.24M in 2028.